These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16854751)

  • 21. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids.
    Noon JP; Evans CE; Haynes WG; Webb DJ; Walker BR
    Br J Dermatol; 1996 May; 134(5):837-42. PubMed ID: 8736322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
    Brown KK; Rehmus WE; Kimball AB
    J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids.
    Bewley A;
    Br J Dermatol; 2008 May; 158(5):917-20. PubMed ID: 18294314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of 3 corticoid preparations with the vasoconstriction and erythema test].
    Früh H
    Z Hautkr; 1983 Mar; 58(5):317-23. PubMed ID: 6845798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic sensitivity to corticosteroids in smokers with asthma.
    Livingston E; Chaudhuri R; McMahon AD; Fraser I; McSharry CP; Thomson NC
    Eur Respir J; 2007 Jan; 29(1):64-71. PubMed ID: 16899479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Clin Exp Dermatol; 1983 Sep; 8(5):489-93. PubMed ID: 6641007
    [No Abstract]   [Full Text] [Related]  

  • 27. Psoriasis: improving adherence to topical therapy.
    Feldman SR; Horn EJ; Balkrishnan R; Basra MK; Finlay AY; McCoy D; Menter A; van de Kerkhof PC;
    J Am Acad Dermatol; 2008 Dec; 59(6):1009-16. PubMed ID: 18835062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin levels and vasoconstrictor assay of topically applied hydrocortisone.
    Wallace SM; Falkenberg HM; Runikis JO; Stewart WD
    Arch Dermatol; 1979 Apr; 115(4):440-1. PubMed ID: 434864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.
    Stoughton RB
    Int J Dermatol; 1992 Oct; 31 Suppl 1():26-8. PubMed ID: 1428464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tachyphylaxis to topical glucocorticoids; what is the evidence?
    Taheri A; Cantrell J; Feldman SR
    Dermatol Online J; 2013 Jul; 19(7):18954. PubMed ID: 24010503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials of topical corticosteroids in psoriasis: correlations with the vasoconstrictor assay.
    Cornell RC
    Int J Dermatol; 1992 Oct; 31 Suppl 1():38-40. PubMed ID: 1428467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Coral reef' psoriasis: a marker of resistance to topical treatment.
    Feldman SR; Brown KL; Heald P
    J Dermatolog Treat; 2008; 19(5):257-8. PubMed ID: 18608734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranking of topical glucocorticoids. Principles and results.
    Smith EW; Haigh JM
    Curr Probl Dermatol; 1993; 21():89-96. PubMed ID: 8299381
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial.
    Faurschou A; Wulf HC
    Arch Dermatol; 2008 May; 144(5):620-4. PubMed ID: 18490588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability and bioequivalence of topical glucocorticoids.
    Wiedersberg S; Leopold CS; Guy RH
    Eur J Pharm Biopharm; 2008 Mar; 68(3):453-66. PubMed ID: 17826047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical steroids and corticophobia.
    Belloni Fortina A; Neri L
    G Ital Dermatol Venereol; 2013 Dec; 148(6):651-4. PubMed ID: 24442046
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of topical vitamin D modulators in psoriasis therapy.
    Tanghetti EA
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s4-8. PubMed ID: 19702030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical therapy for the management of childhood psoriasis: part I.
    Cordoro KM
    Skin Therapy Lett; 2008 Apr; 13(3):1-3. PubMed ID: 18506356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Br J Dermatol; 1983 Jul; 109 Suppl 25():114-6. PubMed ID: 6860578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.